Headlines

Halozyme Therapeutics And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – Halozyme Therapeutics (HALO), W.P. Carey REIT (WPC), Lattice Semiconductor Corporation (LSCC) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Halozyme Therapeutics (HALO)

27.2% sales growth and 105.22% return on equity

Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. Its flagship product is Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in subcutaneous urography and to improve resorption of radiopaque agents. The company also develops Perjeta; RITUXAN HYCELA and MabThera SC for the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia (CLL); RITUXAN SC for patients with CLL; and HYQVIA for the treatment of immunodeficiency disorders. In addition, it is developing Tecentriq for non-small cell lung cancer; OCREVUS for multiple sclerosis; DARZALEX for the treatment of patients with amyloidosis, smoldering myeloma, and multiple myeloma; nivolumab for the treatment of solid tumors; ARGX-113, a human neonatal Fc receptor; ARGX-117 to treat autoimmune diseases; and BMS-986179, an anti-CD-73 antibody. The company has collaborations with F. Hoffmann-La Roche, Ltd.; Hoffmann-La Roche, Inc.; Baxalta US Inc.; Baxalta GmbH; Pfizer Inc.; Janssen Biotech, Inc.; AbbVie, Inc.; Eli Lilly and Company; Bristol-Myers Squibb Company; Alexion Pharma Holding; ARGENX BVBA; Horizon Therapeutics plc; National Institute of Allergy and Infectious Diseases; Centre for the AIDS Programme of Research in South Africa; and ViiV Healthcare Limited for small and large molecule targets for the treatment and prevention of HIV. Halozyme Therapeutics, Inc. was founded in 1998 and is based in San Diego, California.

Earnings Per Share

As for profitability, Halozyme Therapeutics has a trailing twelve months EPS of $1.7.

PE Ratio

Halozyme Therapeutics has a trailing twelve months price to earnings ratio of 21.5. Meaning, the purchaser of the share is investing $21.5 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 105.22%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 45.1%, now sitting on 773.65M for the twelve trailing months.

2. W.P. Carey REIT (WPC)

21% sales growth and 8.91% return on equity

W. P. Carey ranks among the largest net lease REITs with an enterprise value of approximately $18 billion and a diversified portfolio of operationally-critical commercial real estate that includes 1,215 net lease properties covering approximately 142 million square feet as of September 30, 2020. For nearly five decades, the company has invested in high-quality single-tenant industrial, warehouse, office, retail and self-storage properties subject to long-term net leases with built-in rent escalators. Its portfolio is located primarily in the U.S. and Northern and Western Europe and is well-diversified by tenant, property type, geographic location and tenant industry.

Earnings Per Share

As for profitability, W.P. Carey REIT has a trailing twelve months EPS of $3.57.

PE Ratio

W.P. Carey REIT has a trailing twelve months price to earnings ratio of 15.17. Meaning, the purchaser of the share is investing $15.17 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.91%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 29.8%, now sitting on 1.66B for the twelve trailing months.

3. Lattice Semiconductor Corporation (LSCC)

11.3% sales growth and 40.53% return on equity

Lattice Semiconductor Corporation, together with its subsidiaries, develops and sells semiconductor products in Asia, Europe, and the Americas. The company offers field programmable gate arrays that consist of four product families, including the Certus-NX and ECP, MachXO, iCE40, and CrossLink. It also provides video connectivity application specific standard products. In addition, the company licenses its technology portfolio through standard IP and IP core licensing, patent monetization, and IP services. It sells its products directly to end customers, and indirectly through a network of independent manufacturers' representatives and independent distributors. The company primarily serves original equipment manufacturers in the communications and computing, consumer, and industrial and automotive end markets. Lattice Semiconductor Corporation was incorporated in 1983 and is headquartered in Hillsboro, Oregon.

Earnings Per Share

As for profitability, Lattice Semiconductor Corporation has a trailing twelve months EPS of $1.5.

PE Ratio

Lattice Semiconductor Corporation has a trailing twelve months price to earnings ratio of 51.41. Meaning, the purchaser of the share is investing $51.41 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 40.53%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 8.3% and 8.2%, respectively.

Moving Average

Lattice Semiconductor Corporation’s worth is way under its 50-day moving average of $87.22 and below its 200-day moving average of $85.67.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Lattice Semiconductor Corporation’s EBITDA is 215.38.

4. Synergetics USA (SURG)

10.8% sales growth and 130.07% return on equity

SurgePays, Inc., through its subsidiaries, provides telecommunication services in the United States. It offers discounted and free wireless services for federal programs, such as SNAP (EBT) and Medicaid; subsidized wireless service to qualifying low income customers; repaid wireless plans with talk, text, and 4G LTE data; and client acquisition and retention services for attorneys and law firms by operating digital marketing campaigns. The company also provides financial technology tech and wireless top-up platform; and SurgePays Blockchain software, an e-commerce platform, which offer wholesale goods and services direct to convenience stores, bodegas, minimarts, tiendas, and other corner stores. In addition, it provides sales support, customer, IT infrastructure design, graphic media, database programming, software development, revenue assurance, lead generation, call center support, and other services. The company was formerly known as Surge Holdings, Inc. and changed its name to SurgePays, Inc. in November 2020. SurgePays, Inc. is headquartered in Bartlett, Tennessee.

Earnings Per Share

As for profitability, Synergetics USA has a trailing twelve months EPS of $0.85.

PE Ratio

Synergetics USA has a trailing twelve months price to earnings ratio of 5.54. Meaning, the purchaser of the share is investing $5.54 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 130.07%.

Moving Average

Synergetics USA’s value is under its 50-day moving average of $4.81 and way under its 200-day moving average of $5.46.

Revenue Growth

Year-on-year quarterly revenue growth grew by 28.1%, now sitting on 143.06M for the twelve trailing months.

5. Green Brick Partners (GRBK)

9.4% sales growth and 26.35% return on equity

Green Brick Partners, Inc. operates as a homebuilding and land development company in the United States. It operates through Builder operations Central, Builder operations Southeast, and Land development segments. The company is involved in the land acquisition and development, entitlements, design, construction, title and mortgage services, marketing, and sale of townhomes, patio homes, single family homes, and luxury homes in residential neighborhoods, and master planned communities. As of December 31,2021, the company owns or controls approximately 28,600 home sites in Dallas-Forth Worth, Atlanta metropolitan areas, and the Treasure Coast, Florida market. The company sells its homes through sales representatives and independent realtors. Green Brick Partners, Inc. was incorporated in 2006 and is headquartered in Plano, Texas.

Earnings Per Share

As for profitability, Green Brick Partners has a trailing twelve months EPS of $5.82.

PE Ratio

Green Brick Partners has a trailing twelve months price to earnings ratio of 6.91. Meaning, the purchaser of the share is investing $6.91 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.35%.

6. Restaurant Brands International (QSR)

7.9% sales growth and 34.8% return on equity

Restaurant Brands International Inc. operates as a quick-service restaurant company in Canada, the United States, and internationally. It operates through four segments: Tim Hortons (TH), Burger King (BK), Popeyes Louisiana Kitchen (PLK), and Firehouse Subs (FHS). The company owns and franchises TH chain of donut/coffee/tea restaurants that offer blend coffee, tea, and espresso-based hot and cold specialty drinks; and fresh baked goods, including donuts, Timbits, bagels, muffins, cookies and pastries, grilled paninis, classic sandwiches, wraps, soups, and other food products. It is also involved in owning and franchising BK, a fast-food hamburger restaurant chain, which offers flame-grilled hamburgers, chicken and other specialty sandwiches, French fries, soft drinks, and other food items; and PLK quick service restaurants that provide Louisiana-style fried chicken, chicken tenders, fried shrimp and other seafood, red beans and rice, and other regional items. In addition, the company owns and franchises FHS quick service restaurants that offer meats and cheese, chopped salads, chili and soups, signature and other sides, soft drinks, and local specialties. Restaurant Brands International Inc. was founded in 1954 and is headquartered in Toronto, Canada.

Earnings Per Share

As for profitability, Restaurant Brands International has a trailing twelve months EPS of $3.27.

PE Ratio

Restaurant Brands International has a trailing twelve months price to earnings ratio of 20.42. Meaning, the purchaser of the share is investing $20.42 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.8%.

Volume

Today’s last reported volume for Restaurant Brands International is 1331180 which is 11.67% below its average volume of 1507120.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Restaurant Brands International’s EBITDA is 62.32.

Moving Average

Restaurant Brands International’s worth is below its 50-day moving average of $67.18 and below its 200-day moving average of $69.36.

Leave a Reply

Your email address will not be published. Required fields are marked *